Detalles de la búsqueda
1.
Clinical outcomes and prognostic factors of concurrent chemoradiotherapy for anal squamous cell carcinoma in Japan.
Int J Clin Oncol
; 2024 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38819609
2.
Neoadjuvant chemotherapy for borderline resectable colorectal cancer liver metastases: a single-institution retrospective study.
HPB (Oxford)
; 26(2): 282-290, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37985325
3.
Prognostic Impact of Tumor Markers (CEA and CA19-9) on Patients with Resectable Colorectal Liver Metastases Stratified by Tumor Number and Size: Potentially Valuable Biologic Markers for Preoperative Treatment.
Ann Surg Oncol
; 30(12): 7338-7347, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37365416
4.
Adding Induction Chemotherapy Before Chemoradiotherapy with Total Mesorectal Excision and Selective Lateral Lymph Node Dissection for Patients with Poor-Risk, Locally Advanced, Mid-to-Low Rectal Cancer May Improve Oncologic Outcomes: A Propensity Score-Matched Analysis.
Ann Surg Oncol
; 30(8): 4716-4724, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37032405
5.
Single-organ pulmonary metastasis is a favorable prognostic factor in metastatic colorectal cancer patients treated with FOLFIRI and vascular endothelial growth factor inhibitors.
BMC Cancer
; 23(1): 634, 2023 Jul 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37415118
6.
Efficacy of aluminum chloride in severe regorafenib-associated hand-foot skin reactions: a single-arm trial.
BMC Cancer
; 23(1): 401, 2023 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37142953
7.
NEXUS trial: a multicenter phase II clinical study evaluating the efficacy and safety of the perioperative use of encorafenib, binimetinib, and cetuximab in patients with previously untreated surgically resectable BRAF V600E mutant colorectal oligometastases.
BMC Cancer
; 23(1): 779, 2023 Aug 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37605122
8.
Treatment efficacy of ramucirumab-containing chemotherapy in patients with alpha-fetoprotein producing gastric cancer.
Int J Clin Oncol
; 28(1): 121-129, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36409433
9.
Morphological response and tumor shrinkage as predictive factors in metastatic colorectal cancer treated with first-line capecitabine, oxaliplatin, and bevacizumab.
Int J Clin Oncol
; 28(9): 1191-1199, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37349660
10.
Regulation of MEK inhibitor selumetinib sensitivity by AKT phosphorylation in the novel BRAF L525R mutant.
Int J Clin Oncol
; 28(5): 654-663, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36856908
11.
Clinical utility of the carcinoembryonic antigen level in patients with stage III colon cancer after surgery and adjuvant chemotherapy.
Surg Today
; 2023 Dec 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38103076
12.
A modified MethyLight assay predicts the clinical outcomes of anti-epidermal growth factor receptor treatment in metastatic colorectal cancer.
Cancer Sci
; 113(3): 1057-1068, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34962023
13.
Clinical Progress in Inoperable or Recurrent Advanced Gastric Cancer Treatment from 1004 Single Institute Experiences Between 2007 and 2018.
Oncologist
; 27(6): e506-e517, 2022 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35596939
14.
Clinical Usefulness of Postoperative Serum Carcinoembryonic Antigen in Patients with Colorectal Cancer with Liver Metastases.
Ann Surg Oncol
; 29(13): 8385-8393, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35974233
15.
Effect of DNA methylation status on first-line anti-epidermal growth factor receptor treatment in patients with metastatic colorectal cancer.
Int J Colorectal Dis
; 37(6): 1439-1447, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35612620
16.
REMARRY and PURSUIT trials: liquid biopsy-guided rechallenge with anti-epidermal growth factor receptor (EGFR) therapy with panitumumab plus irinotecan for patients with plasma RAS wild-type metastatic colorectal cancer.
BMC Cancer
; 21(1): 674, 2021 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34098908
17.
Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research.
Int J Clin Oncol
; 26(2): 335-344, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33085057
18.
[FOLFIRI plus Ramucirumab Treatment for Metastatic Colorectal Cancer-Narrative Review of Real-World Evidence in Japan].
Gan To Kagaku Ryoho
; 48(6): 797-803, 2021 Jun.
Artículo
en Japonés
| MEDLINE | ID: mdl-34139727
19.
Survival Outcomes of Resected BRAF V600E Mutant Colorectal Liver Metastases: A Multicenter Retrospective Cohort Study in Japan.
Ann Surg Oncol
; 27(9): 3307-3315, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32661852
20.
A Multicenter Phase 2 Trial to Evaluate the Efficacy of mFOLFOX6 + Cetuximab as Induction Chemotherapy to Achieve R0 Surgical Resection for Advanced Colorectal Liver Metastases (NEXTO Trial).
Ann Surg Oncol
; 27(11): 4188-4195, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32514802